A child in sub-Saharan Africa is diagnosed with trachoma. Azithromycin MDA has reduced TF prevalence in her district to 3% in children aged 1-9 years....

Question

A child in sub-Saharan Africa is diagnosed with trachoma. Azithromycin MDA has reduced TF prevalence in her district to 3% in children aged 1-9 years. MDA has been stopped. What surveillance must now occur?

Accepted Answer

Post-MDA surveillance surveys at 2 years after stopping MDA to confirm TF prevalence remains

Answer

No further surveillance is needed

Answer

Annual vaccination of all children

Answer

Monthly stool surveys

Answer

DNA testing of all children

uk-dtmh MCQ (SBA): Post-MDA Trachoma Surveillance

A child in sub-Saharan Africa is diagnosed with trachoma. Azithromycin MDA has reduced TF prevalence in her district to 3% in children aged 1-9 years. MDA has been stopped. What surveillance must now occur?